This is a summary of the European public assessment report (EPAR) for Neoclarityn. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Neoclarityn.
Therapeutic Indication
### Therapeutic indication Neoclarityn is indicated for the relief of symptoms associated with: - allergic rhinitis - urticaria
Therapeutic Area (MeSH)
ATC Code
R06AX27
ATC Item
desloratadine
Pharmacotherapeutic Group
Antihistamines for systemic use
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| desloratadine | N/A | 地氯雷他定 |
EMA Name
Neoclarityn
Medicine Name
Neoclarityn
Aliases
N/A
